July 27, 2009 -- Minneapolis --
Medtronic, Inc. (NYSE:MDT - News) today announced global resolution
of all outstanding intellectual property litigation with Abbott
Laboratories.
Terms of the agreement stipulate that neither party
will sue each other in the field of coronary stent and stent
delivery systems for
a period of at least 10 years, subject to certain conditions. |